62 related articles for article (PubMed ID: 21136691)
1. Reversal of diabetes-evoked changes in mitochondrial protein expression of cardiac left ventricle by treatment with a copper(II)-selective chelator.
Jüllig M; Chen X; Hickey AJ; Crossman DJ; Xu A; Wang Y; Greenwood DR; Choong YS; Schönberger SJ; Middleditch MJ; Phillips AR; Cooper GJ
Proteomics Clin Appl; 2007 Apr; 1(4):387-99. PubMed ID: 21136691
[TBL] [Abstract][Full Text] [Related]
2. Molecular changes evoked by triethylenetetramine treatment in the extracellular matrix of the heart and aorta in diabetic rats.
Gong D; Lu J; Chen X; Choong SY; Zhang S; Chan YK; Glyn-Jones S; Gamble GD; Phillips AR; Cooper GJ
Mol Pharmacol; 2006 Dec; 70(6):2045-51. PubMed ID: 16973718
[TBL] [Abstract][Full Text] [Related]
3. Quantitative proteomic profiling identifies new renal targets of copper(II)-selective chelation in the reversal of diabetic nephropathy in rats.
Gong D; Chen X; Middleditch M; Huang L; Vazhoor Amarsingh G; Reddy S; Lu J; Zhang S; Ruggiero K; Phillips AR; Cooper GJ
Proteomics; 2009 Sep; 9(18):4309-20. PubMed ID: 19634143
[TBL] [Abstract][Full Text] [Related]
4. Triethylenetetramine and metabolites: levels in relation to copper and zinc excretion in urine of healthy volunteers and type 2 diabetic patients.
Lu J; Chan YK; Gamble GD; Poppitt SD; Othman AA; Cooper GJ
Drug Metab Dispos; 2007 Feb; 35(2):221-7. PubMed ID: 17108057
[TBL] [Abstract][Full Text] [Related]
5. Protection of the heart by treatment with a divalent-copper-selective chelator reveals a novel mechanism underlying cardiomyopathy in diabetic rats.
Zhang L; Ward ML; Phillips AR; Zhang S; Kennedy J; Barry B; Cannell MB; Cooper GJ
Cardiovasc Diabetol; 2013 Aug; 12():123. PubMed ID: 23981320
[TBL] [Abstract][Full Text] [Related]
6. Transcriptomic analysis of the cardiac left ventricle in a rodent model of diabetic cardiomyopathy: molecular snapshot of a severe myocardial disease.
Glyn-Jones S; Song S; Black MA; Phillips AR; Choong SY; Cooper GJ
Physiol Genomics; 2007 Feb; 28(3):284-93. PubMed ID: 17062650
[TBL] [Abstract][Full Text] [Related]
7. Diabetic cardiomyopathy is associated with defective myocellular copper regulation and both defects are rectified by divalent copper chelation.
Zhang S; Liu H; Amarsingh GV; Cheung CC; Hogl S; Narayanan U; Zhang L; McHarg S; Xu J; Gong D; Kennedy J; Barry B; Choong YS; Phillips AR; Cooper GJ
Cardiovasc Diabetol; 2014 Jun; 13():100. PubMed ID: 24927960
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of myocardial apoptosis by alpha-lipoic acid through suppression of mitochondrial oxidative stress to reduce diabetic cardiomyopathy.
Li CJ; Zhang QM; Li MZ; Zhang JY; Yu P; Yu DM
Chin Med J (Engl); 2009 Nov; 122(21):2580-6. PubMed ID: 19951573
[TBL] [Abstract][Full Text] [Related]
9. Copper(II)-selective chelation improves function and antioxidant defences in cardiovascular tissues of rats as a model of diabetes: comparisons between triethylenetetramine and three less copper-selective transition-metal-targeted treatments.
Lu J; Gong D; Choong SY; Xu H; Chan YK; Chen X; Fitzpatrick S; Glyn-Jones S; Zhang S; Nakamura T; Ruggiero K; Obolonkin V; Poppitt SD; Phillips AR; Cooper GJ
Diabetologia; 2010 Jun; 53(6):1217-26. PubMed ID: 20221822
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of copper chelation with triethylenetetramine in managing diabetes mellitus and Alzheimer's disease.
Cooper GJ
Drugs; 2011 Jul; 71(10):1281-320. PubMed ID: 21770477
[TBL] [Abstract][Full Text] [Related]
11. Treatment with a copper-selective chelator causes substantive improvement in cardiac function of diabetic rats with left-ventricular impairment.
Lu J; Pontré B; Pickup S; Choong SY; Li M; Xu H; Gamble GD; Phillips AR; Cowan BR; Young AA; Cooper GJ
Cardiovasc Diabetol; 2013 Jan; 12():28. PubMed ID: 23368770
[TBL] [Abstract][Full Text] [Related]
12. Characterization of proteomic changes in cardiac mitochondria in streptozotocin-diabetic rats using iTRAQ™ isobaric tags.
Jüllig M; Hickey AJ; Middleditch MJ; Crossman DJ; Lee SC; Cooper GJ
Proteomics Clin Appl; 2007 Jun; 1(6):565-76. PubMed ID: 21136708
[TBL] [Abstract][Full Text] [Related]
13. Biphasic response of skeletal muscle mitochondria to chronic cardiac pressure overload - role of respiratory chain complex activity.
Schrepper A; Schwarzer M; Schöpe M; Amorim PA; Doenst T
J Mol Cell Cardiol; 2012 Jan; 52(1):125-35. PubMed ID: 22100228
[TBL] [Abstract][Full Text] [Related]
14. Early administration of trimetazidine may prevent or ameliorate diabetic cardiomyopathy.
Wenmeng W; Qizhu T
Med Hypotheses; 2011 Feb; 76(2):181-3. PubMed ID: 20932648
[TBL] [Abstract][Full Text] [Related]
15. Expression changes of mitogen-activated protein kinase phosphatase-1 (MKP-1) in myocardium of streptozotocin-induced diabetic rats.
Weng Y; Shen F; Li J; Shen Y; Zhang X
Exp Clin Endocrinol Diabetes; 2007 Jul; 115(7):455-60. PubMed ID: 17647144
[TBL] [Abstract][Full Text] [Related]
16. Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formation.
Rosca MG; Mustata TG; Kinter MT; Ozdemir AM; Kern TS; Szweda LI; Brownlee M; Monnier VM; Weiss MF
Am J Physiol Renal Physiol; 2005 Aug; 289(2):F420-30. PubMed ID: 15814529
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics, pharmacodynamics, and metabolism of triethylenetetramine in healthy human participants: an open-label trial.
Lu J; Poppitt SD; Othman AA; Sunderland T; Ruggiero K; Willett MS; Diamond LE; Garcia WD; Roesch BG; Cooper GJ
J Clin Pharmacol; 2010 Jun; 50(6):647-58. PubMed ID: 20145262
[TBL] [Abstract][Full Text] [Related]
18. Sequential changes of energy metabolism and mitochondrial function in myocardial infarction induced by isoproterenol in rats: a long-term and integrative study.
Chagoya de Sánchez V; Hernández-Muñoz R; López-Barrera F; Yañez L; Vidrio S; Suárez J; Cota-Garza MD; Aranda-Fraustro A; Cruz D
Can J Physiol Pharmacol; 1997 Dec; 75(12):1300-11. PubMed ID: 9580216
[TBL] [Abstract][Full Text] [Related]
19. Preservation of ventricular performance at early stages of diabetic cardiomyopathy involves changes in myocyte size, number and intercellular coupling.
Stilli D; Lagrasta C; Berni R; Bocchi L; Savi M; Delucchi F; Graiani G; Monica M; Maestri R; Baruffi S; Rossi S; Macchi E; Musso E; Quaini F
Basic Res Cardiol; 2007 Nov; 102(6):488-99. PubMed ID: 17585379
[TBL] [Abstract][Full Text] [Related]
20. Insulin treatment decreases the antioxidant defense mechanism in experimental diabetes.
Somogyi A; Ruzicska E; Blázovics A; Vér A; Rosta K; Tóth M
Med Sci Monit; 2005 Jul; 11(7):BR206-11. PubMed ID: 15990681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
